Development of MRI protocols for radiotherapy planning

MRI Development for Radiotherapy Planning and Delivery in Non-Patient Volunteers

Observational The Christie NHS Foundation Trust · NCT04749134

This study is testing new MRI scanning methods to improve how doctors plan and deliver radiotherapy for cancer patients, using non-patient volunteers.

Quick facts

Study typeObservational
Enrollment500 (estimated)
Ages16 Years and up
SexAll
SponsorThe Christie NHS Foundation Trust Academic / other
Locations1 site (Manchester)
Trial IDNCT04749134 on ClinicalTrials.gov

What this trial studies

This study involves non-patient volunteers who will undergo MRI scans using advanced MR-Linac and MRSIM technologies. The primary aim is to develop, optimize, and validate MRI protocols that can enhance radiotherapy planning and delivery. Participants will be required to provide written consent and undergo MRI safety screening, with their scans being read by a clinical radiologist for any incidental findings. The study is observational and does not involve any treatment interventions.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals aged 16 and older who are willing to participate as non-patient volunteers and can safely undergo MRI scans.

Not a fit: Patients with contraindications to MRI or those who are unable to tolerate an MRI scan will not benefit from this study.

Why it matters

Potential benefit: If successful, this study could lead to improved MRI protocols that enhance the accuracy and effectiveness of radiotherapy for cancer patients.

How similar studies have performed: While this study focuses on MRI protocol development, similar studies have shown promise in enhancing imaging techniques for radiotherapy, indicating a potential for success.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Willing and able to provide written consent
* Volunteers must undergo and satisfy MRI safety screening
* Volunteers must be ≥ 16 years of age
* Participants must agree to registration as a non-patient in CWP (the Trust's Electronic Health Record - EHR- system) and have their MRIs read and reported for incidental findings by a clinical radiologist

Exclusion Criteria:

* Any contraindications to MRI identified after MRI safety screening including completion of an MRI Safety Screening Form
* Unable to tolerate MRI scan
* Known Pregnancy
* Known or suspected pathology in body region to be scanned
* Member of study team

Where this trial is running

Manchester

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Focus of the Study is MRI Sequence Development
Last reviewed 2026-06-09 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.